|
All Clinical trials
Citations 171-180 of 604 total displayed.
|
Past content
(since Jan 2000):
|
- EDITORIALS
Lowering cholesterol in patients with stroke: Raising the standard
- Mitchell S.V. Elkind and Curtis G. Benesch
Neurology 2006; 66: 1140-1141.
[Full text]
[PDF]
- ARTICLES
Is IV tissue plasminogen activator beneficial in patients with hyperdense artery sign?
- A. I. Qureshi, M. A. Ezzeddine, A. Nasar, M.F.K. Suri, J. F. Kirmani, N. Janjua, and A. A. Divani
Neurology 2006; 66: 1171-1174.
[Abstract]
[Full text]
[PDF]
- ARTICLES
Selegiline slows the progression of the symptoms of Parkinson disease
- S. Pålhagen, E. Heinonen, J. Hägglund, T. Kaugesaar, O. Mäki-Ikola, R. Palm, and the Swedish Parkinson Study Group
Neurology 2006; 66: 1200-1206.
[Abstract]
[Full text]
[PDF]
- ARTICLES
Identification of potential CSF biomarkers in ALS
- G. M. Pasinetti, L. H. Ungar, D. J. Lange, S. Yemul, H. Deng, X. Yuan, R. H. Brown, M. E. Cudkowicz, K. Newhall, E. Peskind, S. Marcus, and L. Ho
Neurology 2006; 66: 1218-1222.
[Abstract]
[Full text]
[PDF]
- BRIEF COMMUNICATIONS
Mycophenolate mofetil in dermatomyositis: Is it safe?
- J. Rowin, A. A. Amato, N. Deisher, J. Cursio, and M. N. Meriggioli
Neurology 2006; 66: 1245-1247.
[Abstract]
[Full text]
[PDF]
- ARTICLES
A randomized study of two interferon- beta treatments in relapsing–remitting multiple sclerosis
- N. Koch-Henriksen, P. S. Sørensen, T. Christensen, J. Frederiksen, M. Ravnborg, K. Jensen, A. Heltberg, O. Kristensen, E. Stenager, T. Petersen, T. Hansen for the Danish Multiple Sclerosis Group
Neurology 2006; 66: 1056-1060.
[Abstract]
[Full text]
[PDF]
- BRIEF COMMUNICATIONS
Randomized controlled phase II trial of glatiramer acetate in ALS
- P. H. Gordon, C. Doorish, J. Montes, R. L. Mosley, B. Diamond, R. B. MacArthur, L. H. Weimer, P. Kaufmann, A. P. Hays, L. P. Rowland, H. E. Gendelman, S. Przedborski, and H. Mitsumoto
Neurology 2006; 66: 1117-1119.
[Abstract]
[Full text]
[PDF]
- ARTICLES
A Phase II study of the safety and efficacy of teriflunomide in multiple sclerosis with relapses
- P. W. O’Connor, D. Li, M. S. Freedman, A. Bar-Or, G.P.A. Rice, C. Confavreux, D. W. Paty, J. A. Stewart, R. Scheyer on behalf of the Teriflunomide Multiple Sclerosis Trial Group and the University of British Columbia MS/MRI Research Group
Neurology 2006; 66: 894-900.
[Abstract]
[Full text]
[PDF]
- BRIEF COMMUNICATIONS
Valproic acid adjunctive therapy for HIV-associated cognitive impairment: A first report
- G. Schifitto, D. R. Peterson, J. Zhong, H. Ni, K. Cruttenden, M. Gaugh, H. E. Gendelman, M. Boska, and H. Gelbard
Neurology 2006; 66: 919-921.
[Abstract]
[Full text]
[PDF]
- VIEWS & REVIEWS
Optimizing the ongoing search for new treatments for Parkinson disease: Using futility designs
- B. C. Tilley, Y. Y. Palesch, K. Kieburtz, B. Ravina, P. Huang, J. J. Elm, K. Shannon, G. F. Wooten, C. M. Tanner, G. C. Goetz on behalf of the NET-PD Investigators
Neurology 2006; 66: 628-633.
[Abstract]
[Full text]
[PDF]
|
|
